NCT00879684View on ClinicalTrials.gov

Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Advanced Solid TumorsNeoplasmsCarcinomaCancerMalignancy
Interventions
BIOLOGICAL

CVX-060

Weekly, intravenous dose

Trial Locations (4)

19111

Fox Chase Cancer Center, Philadelphia

85255

Scottsdale Medical Imaging, Ltd., Scottsdale

85258

Premiere Oncology of Arizona, Scottsdale

90404

Premiere Oncology, A Medical Corporation, Santa Monica

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00879684 - Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter